Literature DB >> 15464145

Secrets of the opium poppy revealed.

Christopher J Evans1.   

Abstract

Studies concerning drugs of abuse have made major contributions in defining the circuitry, as well as cellular and molecular substrates that underlie certain behaviors. Opiate drugs for example, have revealed important insights concerning pain perception and reward. Up to the late 1960s, opiate drugs were suspected to work by mysteriously perturbing lipid membrane structure. We now know the following: the sequence and neuroanatomy of the G-protein coupled receptors that mediate opiate effects; that many proteins interact with opioid receptors such as G-protein sub-unit combinations, G-protein receptor kinases, arrestins and calmodulin; that many signaling molecules are modulated by opioid receptors, including ion channels, kinase cascades and adenyl cyclase. More than 20 different peptides, excised from three precursor proteins by specific proteases, have been shown to be endogenous ligands for opioid receptors. Revealing the molecules of the endogenous opioid system has inspired efforts for developing new opioid analgesics with the hope of minimizing abuse potential. This article will detail the current rationale for searching for less-addictive opiate analgesics and speculate on the future of drug abuse research in furthering our understanding of neural plasticity and the underpinnings of addictive behavior.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15464145     DOI: 10.1016/j.neuropharm.2004.06.016

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  12 in total

Review 1.  Ligand-directed signalling within the opioid receptor family.

Authors:  Amynah A Pradhan; Monique L Smith; Brigitte L Kieffer; Christopher J Evans
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

Review 2.  Opioid glycopeptide analgesics derived from endogenous enkephalins and endorphins.

Authors:  Yingxue Li; Mark R Lefever; Dhanasekaran Muthu; Jean M Bidlack; Edward J Bilsky; Robin Polt
Journal:  Future Med Chem       Date:  2012-02       Impact factor: 3.808

Review 3.  Opioid pharmaceuticals and addiction: the issues, and research directions seeking solutions.

Authors:  Wendy M Walwyn; Karen A Miotto; Christopher J Evans
Journal:  Drug Alcohol Depend       Date:  2010-02-25       Impact factor: 4.492

Review 4.  Role of the mu-opioid receptor in opioid modulation of immune function.

Authors:  Jana Ninković; Sabita Roy
Journal:  Amino Acids       Date:  2011-12-15       Impact factor: 3.520

Review 5.  Regulation of μ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance.

Authors:  John T Williams; Susan L Ingram; Graeme Henderson; Charles Chavkin; Mark von Zastrow; Stefan Schulz; Thomas Koch; Christopher J Evans; Macdonald J Christie
Journal:  Pharmacol Rev       Date:  2013-01-15       Impact factor: 25.468

6.  Alternative splicing determines the post-endocytic sorting fate of G-protein-coupled receptors.

Authors:  Michael Tanowitz; James N Hislop; Mark von Zastrow
Journal:  J Biol Chem       Date:  2008-10-20       Impact factor: 5.157

Review 7.  Opioid receptors: from binding sites to visible molecules in vivo.

Authors:  Brigitte L Kieffer; Christopher J Evans
Journal:  Neuropharmacology       Date:  2008-08-05       Impact factor: 5.250

8.  Brain region specific actions of regulator of G protein signaling 4 oppose morphine reward and dependence but promote analgesia.

Authors:  Ming-Hi Han; Willam Renthal; Robert H Ring; Zia Rahman; Kassi Psifogeorgou; David Howland; Shari Birnbaum; Kathleen Young; Rachael Neve; Eric J Nestler; Venetia Zachariou
Journal:  Biol Psychiatry       Date:  2009-11-14       Impact factor: 13.382

9.  Long-term opiate use and risk of cardiovascular mortality: results from the Golestan Cohort Study.

Authors:  Mahdi Nalini; Ramin Shakeri; Hossein Poustchi; Akram Pourshams; Arash Etemadi; Farhad Islami; Masoud Khoshnia; Abdolsamad Gharavi; Gholamreza Roshandel; Hooman Khademi; Mahdi Zahedi; Behnoush Abedi-Ardekani; Rajesh Vedanthan; Paolo Boffetta; Sanford M Dawsey; Paul D Pharaoh; Masoud Sotoudeh; Christian C Abnet; Nicholas E Day; Paul Brennan; Farin Kamangar; Reza Malekzadeh
Journal:  Eur J Prev Cardiol       Date:  2021-03-23       Impact factor: 7.804

10.  Morphine and microRNA Activity: Is There a Relation with Addiction?

Authors:  Raquel E Rodríguez
Journal:  Front Genet       Date:  2012-11-09       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.